Jyothis George

Jyothis George

Company: Novo Nordisk

Job title: Vice President - Clinical Development, Medical Affairs & Regulatory,

Seminars:

Moderated Discussion – Is HFpEF a Systemic or a Heart Disease? 5:30 pm

Read more

day: Day Two

Is Heart Failure with Preserved Ejection Fraction (HFpEF) a Metabolic Disease? 5:00 pm

Understand the metabolic syndrome and the major role obesity plays in this field Highlight the correlation of obesity with HFpEF Discuss effective methods to distinguish between obese patients with HFpEF from patients with other comorbiditiesRead more

day: Day Two

Moderated Discussion – Should We Be Planning for Combination Approaches? 12:15 pm

Read more

day: Day Two

Translating the Role of GLP 1 in Heart Failure in the Cardiorenal syndrome 11:15 am

Discuss how GLP 1 improves diastolic function and survival in HFpEF patients Understand how it has emerged as a promising drug to restore metabolic perturbations, and may have value in the treatment of the cardiometabolic HFpEF phenotypeRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.